←
Ella Kazerooni 〽️3,280 posts
Ella Kazerooni 〽️ avatar

Ella Kazerooni 〽️

@ellakaz
◷ Joined April 2009▧ 123 Photos and videos
Ella Kazerooni 〽️ avatar
Ella Kazerooni 〽️@ellakaz·12 Oct 2021

Language matters. Period. A diagnosis or risk factor doesn’t define a person. Check yourself & team with coaching and polite reminders. Patient-first non-stigmatizing language improves patient outcomes. We can all do better ! @NLCRTnews @ASCO @IASLC

"A smoker is an individual who smokes. A lung cancer patient is a patient with lung cancer." 💬 @ellakaz Read more in the #ACRBulletin screening special issue 👉 https://t.co/RgdQp0zVEr 👈

Post attachment
LiveLung avatar
⟳ Ella Kazerooni 〽️ retweeted
LiveLung@LiveLung1·23h

“There’s a stigma with this disease that we are really trying to get rid of,” Donaldson said. “Nobody deserves lung cancer regardless of your smoking history. Nobody deserves lung cancer and everyone deserves compassionate care.” #LiveLung #LungCancer #DustyDonaldson #SkanVan #LCAM

Post attachment
ALCSI avatar
⟳ Ella Kazerooni 〽️ retweeted
ALCSI@AmLungCSI·Nov 15

UMich ALCSI celebrated its 5th annual Lung Cancer Screening Day!! 🫁💙 The lung cancer screening center opened its doors on a Saturday to help community members get screened and make early detection more accessible! In addition to raising awareness about lung cancer screening, our team provided resources on radon testing and tobacco cessation. We are grateful to everyone who took the time to stop by and get screened! And, a special thank you to the screening center staff for making this event possible! Events like these are an important opportunity to increase awareness, connect individuals with valuable resources, and emphasize the importance of early detection!!! 💙 #LungCancerScreeningDay #LungCancerAwareness #EarlyDetection #LungHealth #UMich #ALCSI

Post attachment
ALCSI avatar
⟳ Ella Kazerooni 〽️ retweeted
ALCSI@AmLungCSI·Nov 1

November is Lung Cancer Awareness Month! 🫁🤍 This month serves as a reminder of the importance of education, early detection, and continued progress in the fight against lung cancer. As ALCSI, we believe that meaningful change starts with awareness and grows through the collective efforts of students, researchers, healthcare professionals, advocates, and survivors. Despite advances in prevention, screening, and treatment, lung cancer remains the leading cause of cancer-related deaths worldwide. Early detection is one of the most powerful tools we have to improve outcomes, yet many eligible individuals remain unscreened. Did you know? The U.S. Preventive Services Task Force recommends annual low-dose CT screening for adults ages 50-80 with at least a 20 pack-year smoking history who currently smoke or quit within the past 15 years. Throughout November, we encourage our community to learn more about lung cancer, share resources, challenge stigma, and start conversations about the importance of screening. Together, we can raise awareness, inspire advocacy, and work toward a future where fewer lives are lost to lung cancer. Every conversation counts. 🤍 #LungCancerAwarenessMonth #LCAM2026 #LungCancerAwareness #EarlyDetectionSavesLives #ALCSI #LungCancerAdvocacy

Post attachment
Jeff Yang MD FACS avatar
⟳ Ella Kazerooni 〽️ retweeted
Jeff Yang MD FACS@ChiFuJeffYang·Oct 21

We had a great time talking about lung cancer screening at the American Academy of Family Physicians' Annual Meeting (FMX), and we're honored that ALCSI got to host this first-ever, trailblazing session!! Thank you to our esteemed panel, sponsors and to Lauren Rosenthal and Priyanka Senthil (@PriyankaSenth16) for chairing this session. Also, a big shoutout and thank you to Suchir Ryali for organizing this and to our Lipscomb University and Vanderbilt University ALCSI teams for raising awareness about lung cancer screening!! Please stop by our ALCSI booth (#2809) at #AAFPFMX!! Right now, only 25% of people who qualify for lung cancer screening are getting screened. To increase uptake, we really need the leadership of family physicians! Thank you to @aafp and to all the primary care providers who work hard every day to get their patients screened!

Post attachmentPost attachmentPost attachmentPost attachment
Melina Hosseiny, MD avatar
⟳ Ella Kazerooni 〽️ retweeted
Melina Hosseiny, MD@MelinaHosseiny·Oct 12

✅Fantastic morning moderating Cardiothoracic Imaging 2026 session at #SABI26! ✨An absolute pleasure to share the stage with an outstanding lineup of experts: Dr. Jared Christensen Dr. Jeffrey Kanne Dr. Patricia Mergo Dr. Jill Jacobs Dr.Lynn Koweek Dr. Muhammad Umair Dr. Ella Kazerooni From cutting edge science to a lively debate, what an engaging session! 💯 Grateful to our amazing speakers and audience! 👏 #SABI2026 #Radiology #Savannah

Post attachmentPost attachmentPost attachment
LiveLung avatar
⟳ Ella Kazerooni 〽️ retweeted
LiveLung@LiveLung1·Oct 8

Meet the Lung Cancer Network. Our private Facebook community is for anyone impacted by lung cancer - including patients, survivors, care partners, family, and friends. Inside the group, you’ll find:
• Peer-to-peer connection
• Educational resources
• Exclusive live events 
• Expert information
• Lung cancer research updates
• LiveLung event announcements There’s always room for you in our community. Join the Lung Cancer Network: facebook.com/groups/lcnetwor… #LungCancer #LungCancerCommunity #LungCancerSupport

Post attachment
LiveLung avatar
⟳ Ella Kazerooni 〽️ retweeted
LiveLung@LiveLung1·Oct 5

Looking for connection and community during your cancer survivorship journey? The Cancer Survivor Book Club for Women is a free, monthly virtual support group for women cancer survivors at all stages of survivorship - from diagnosis and treatment to post-treatment and beyond. Each month, the group comes together to discuss fiction, nonfiction, and poetry featuring women navigating challenges with strength, resilience, and perseverance. The group meets virtually on the 3rd Wednesday of each month at 12 PM ET and is limited to 15 participants. Learn more and register through Rainwater Counseling: lisarainwatercounseling.com/… A great reminder that sometimes, connection can be found in the pages of a book—and in the people we share them with.

Post attachment
LiveLung avatar
⟳ Ella Kazerooni 〽️ retweeted
LiveLung@LiveLung1·Oct 4

October is Breast Cancer Awareness Month, and there’s an important connection worth talking about. A 2025 study of 75,951 women from the PLCO Cancer Screening Trial found that women with a previous breast cancer diagnosis had a higher incidence of subsequent primary lung cancer compared with women without a breast cancer diagnosis. Read the study: pubmed.ncbi.nlm.nih.gov/4037… Cancer survivorship doesn’t always mean the cancer journey is over. Continued awareness, follow-up care, and conversations about your individual health risks matter. If you’ve experienced both breast cancer and lung cancer, you are not alone. Your story belongs in this community. #BreastCancerAwareness #LungCancer #CancerSurvivor #LungCancerCommunity

Post attachment
Jill Feldman avatar
⟳ Ella Kazerooni 〽️ retweeted
Jill Feldman@jillfeldman4·Oct 3

New research deepens our understanding of inherited #lungcancer risk. Researchers analyzed genetic data from 3.3M+ people to better understand germline #EGFR T790M, a rare inherited mutation. Key points: 👉 Germline ≠ somatic. Finding T790M in a tumor does not mean it was inherited 👉 Carriers had 25× higher odds of lung cancer, but the mutation is rare—about 1 in 15,000 people 👉 It explains some familial lung cancer, but not all. I’m not a carrier despite 3 generations of lung cancer in my family The research gets us closer to the questions that matter: Who should be screened? When should screening start? How often? And ultimately, how do we find lung cancer earlier, when it’s most treatable? Help spread the word about our Lung Cancer Genetics Study. Together, we can make a difference in the fight against lung cancer 23andme.org/lung-cancer/ Huge thanks to the Susan Wojcicki Foundation, @23andMe, and everyone involved. #EGFR #T790M #FamilialLungCancer #GermlineMutations #GeneticRisk @EGFRResisters science.org/doi/10.1126/scie…

Jeff Yang MD FACS avatar
⟳ Ella Kazerooni 〽️ retweeted
Jeff Yang MD FACS@ChiFuJeffYang·Sep 27

Today at #ITSOS2026, Alex Potter (@alexandra_p_24) presented the first results of the INSPIRE study!! Among 518 Black women, the lung cancer detection rate was 1.2%. Among women who smoked for >20 years but were ineligible under USPSTF criteria, it was 1.6%—compared with 1.0% in NLST. These findings support evaluating smoking duration in screening eligibility (#PotterCriteria). This has been a years-long effort, and we’re not done yet. We are now screening Black men and women at risk for lung cancer, with a goal of reaching more than 2,000 people. We look forward to sharing that update by 2029!! #AATS #Lungcancerscreening #ALCSI

Post attachmentPost attachment
Lauren Kriger Groner avatar
⟳ Ella Kazerooni 〽️ retweeted
Lauren Kriger Groner@LaurenGroner·Sep 25

Outstanding #GrandRounds by Dr. Coral Olazagasti, where she shared her diverse and impactful research portfolio! 🙌 Especially pleased to see her highlight her work around #LungCancerScreening w more inclusive guidelines across our diverse South Florida population! 🧡💚👏👏👏

Post attachmentPost attachmentPost attachmentPost attachment
LUNGevity Foundation avatar
⟳ Ella Kazerooni 〽️ retweeted
LUNGevity Foundation@LUNGevity·Sep 23

Cancer death rates have fallen for over 20 years straight, and progress in lung cancer is a large reason for that change -- according to a recent report issued by the CDC, NCI, ACS, and NAACCR. Lung cancer is still the leading cause of cancer death in the country. But we've been making steady improvements: fewer people have tobacco exposure, we have better screening options, and there are more treatment options available. We know progress like this doesn't happen from any one thing. It takes research funding, early detection technologies, policy improvements, patient advocacy and more -- all working together to build momentum and lasting change. Learn more here: cdc.gov/media/releases/2026/… @theNCI @AmericanCancer @NAACCR #LungCancer #CancerResearch #PublicHealth #Oncology